A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.

Schildcrout JS, Shi Y, Danciu I, Bowton E, Field JR, Pulley JM, Basford MA, Gregg W, Cowan JD, Harrell FE, Roden DM, Peterson JF, Denny JC
J Clin Epidemiol. 2016 72: 107-15

PMID: 26628336 · PMCID: PMC4779720 · DOI:10.1016/j.jclinepi.2015.08.028

MeSH Terms (25)

Adult Aged Age Factors Clopidogrel Decision Support Systems, Clinical Drug Utilization Electronic Health Records Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Longitudinal Studies Male Middle Aged Models, Statistical Pharmacogenetics Predictive Value of Tests Prognosis Program Evaluation Proportional Hazards Models Reproducibility of Results Risk Factors Sex Factors Ticlopidine United States Warfarin

Connections (2)

This publication is referenced by other Labnodes entities: